Robin Hayes
New Trial Aims to Transform Rectal Cancer Treatment by Enhancing Radiation Response
In a groundbreaking phase 1 clinical trial at City of Hope®, one of the largest and most advanced cancer research and treatment centers in the U.S., researchers are exploring an innovative approach to treating rectal cancer. The trial seeks to transform rectal cancer—a disease notorious for its resistance to radiation—into a form that is much more responsive to radiation and chemotherapy. This new strategy, which uses the investigational drug papaverine, could pave the way for less invasive treatment options and dramatically improve the quality of life for patients.
· 6 min read
